1. Home
  2. BCLI vs GLXG Comparison

BCLI vs GLXG Comparison

Compare BCLI & GLXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCLI
  • GLXG
  • Stock Information
  • Founded
  • BCLI 2000
  • GLXG 2013
  • Country
  • BCLI United States
  • GLXG Hong Kong
  • Employees
  • BCLI N/A
  • GLXG N/A
  • Industry
  • BCLI Biotechnology: Biological Products (No Diagnostic Substances)
  • GLXG
  • Sector
  • BCLI Health Care
  • GLXG
  • Exchange
  • BCLI Nasdaq
  • GLXG NYSE
  • Market Cap
  • BCLI 13.5M
  • GLXG 15.8M
  • IPO Year
  • BCLI N/A
  • GLXG 2024
  • Fundamental
  • Price
  • BCLI $1.89
  • GLXG $1.22
  • Analyst Decision
  • BCLI Strong Buy
  • GLXG
  • Analyst Count
  • BCLI 1
  • GLXG 0
  • Target Price
  • BCLI $30.00
  • GLXG N/A
  • AVG Volume (30 Days)
  • BCLI 109.6K
  • GLXG 3.2M
  • Earning Date
  • BCLI 11-14-2024
  • GLXG 02-16-2025
  • Dividend Yield
  • BCLI N/A
  • GLXG N/A
  • EPS Growth
  • BCLI N/A
  • GLXG N/A
  • EPS
  • BCLI N/A
  • GLXG 0.04
  • Revenue
  • BCLI N/A
  • GLXG $3,858,088.00
  • Revenue This Year
  • BCLI N/A
  • GLXG N/A
  • Revenue Next Year
  • BCLI N/A
  • GLXG N/A
  • P/E Ratio
  • BCLI N/A
  • GLXG $27.68
  • Revenue Growth
  • BCLI N/A
  • GLXG N/A
  • 52 Week Low
  • BCLI $1.05
  • GLXG $0.70
  • 52 Week High
  • BCLI $11.85
  • GLXG $16.93
  • Technical
  • Relative Strength Index (RSI)
  • BCLI 44.80
  • GLXG N/A
  • Support Level
  • BCLI $1.90
  • GLXG N/A
  • Resistance Level
  • BCLI $2.17
  • GLXG N/A
  • Average True Range (ATR)
  • BCLI 0.18
  • GLXG 0.00
  • MACD
  • BCLI -0.05
  • GLXG 0.00
  • Stochastic Oscillator
  • BCLI 4.76
  • GLXG 0.00

About BCLI Brainstorm Cell Therapeutics Inc.

Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Progressive Multiple Sclerosis (PMS), and Parkinson's disease (PD). Brainstorm's NurOwn, its proprietary process for the propagation of Mesenchymal Stem Cells (MSC) and differentiation into neurotrophic factor-(NTF) secreting cells (MSC-NTF), and their transplantation at, or near, the site of damage, offers the hope of more effectively treating neurodegenerative diseases.

About GLXG GALAXY PAYROLL GROUP LTD

Galaxy Payroll Group Ltd provides payroll outsourcing, employment, consultancy, and market research services based in Hong Kong. Its client base includes retail, trading, industrial, IT, financial, and professional services industries. Geographically, the company derives maximum revenue from its clients in the People's Republic of China and the rest from Hong Kong, Macau, Taiwan, Japan, Thailand, Singapore, and other countries.

Share on Social Networks: